Condition
Soft Tissue Sarcomas clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Soft Tissue Sarcomas clinical trials that are recruiting, at sites in 3 countries (most in United States (3), France (1), China (1)). By phase: Phase 1 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Soft Tissue Sarcomas clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SHY-ONC6: a new anti-cancer drug tested in adults with advanced solid tumors | Phase 1 | Scottsdale, Arizona and 2 other locations | Recruiting | Jul 15, 2026 |
| Pazopanib added to a multi-drug regimen for kids and young adults with recurrent soft tissue sarcomas | Phase 1 | Houston, Texas | Recruiting | Mar 3, 2026 |
| Combining immune therapy with chemotherapy for advanced soft tissue sarcoma | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Feb 27, 2025 |
| Shorter radiation treatment followed by surgery for soft tissue sarcomas | Phase 2 | Nashville, Tennessee | Recruiting | Aug 10, 2020 |
| Evaluating the CINSARC biomarker in soft-tissue sarcomas and chemotherapy effectiveness | — | Bordeaux and 9 other locations | Recruiting | Jun 3, 2016 |
All recruiting trials (5)
-
SHY-ONC6: a new anti-cancer drug tested in adults with advanced solid tumors
This early-phase study tests SHY-ONC6 to see if it is safe and can help people with advanced solid tumors after standard therapies have failed.
-
Pazopanib added to a multi-drug regimen for kids and young adults with recurrent soft tissue sarcomas
This study tests whether adding pazopanib to a regimen of trabectedin, ipilimumab, and nivolumab is safe and possibly beneficial for children and young adults with recurrent soft tissue sarcomas.
-
Combining immune therapy with chemotherapy for advanced soft tissue sarcoma
This study is testing if combining a new immune therapy with standard chemotherapy can help people with advanced soft tissue sarcoma who can’t have surgery or radiation feel better and live longer.
-
Shorter radiation treatment followed by surgery for soft tissue sarcomas
This study is testing if a shorter radiation treatment followed by surgery can help people with soft tissue sarcomas while causing fewer side effects.
-
Evaluating the CINSARC biomarker in soft-tissue sarcomas and chemotherapy effectiveness
This study is testing if a specific genetic marker can help predict how well chemotherapy will work for patients with non-metastatic soft-tissue sarcomas.
Related topics
Quick answers
How many Soft Tissue Sarcomas clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), France (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.